Citation

Jones GM, Nock MK. Sci. Rep. 2022; 12(1): 16976.

Copyright

(Copyright © 2022, Nature Publishing Group)

DOI

10.1038/s41598-022-18645-3

PMID

36216840

PMCID

PMC9551032

Abstract

Psychedelic compounds have been linked to salutary mental health outcomes in both naturalistic and clinical settings; however, current research on psychedelics suffers from a lack of inclusion and focus on racial and ethnic minorities. Thus, the goal of our study was to assess whether race and ethnicity moderate the associations that naturalistic lifetime MDMA (3,4-Methylenedioxymethamphetamine) use and psilocybin use share with past month psychological distress and past year suicidality (ideation and planning). Using data from the National Survey on Drug Use and Health (NSDUH) (2008-2019) (N = 484,732), we conducted survey-weighted multivariable logistic regression to conduct interaction tests and to assess the associations that MDMA use and psilocybin use share with the aforementioned outcomes for each racial and ethnic group. Race and ethnicity significantly moderated the associations between MDMA and psilocybin use and psychological distress and suicidality. For White participants, MDMA and psilocybin use conferred lowered odds of all distress and suicidality outcomes. For racial and ethnic minority participants, the associations between psychedelic use and suicidality were far fewer. These findings invite further research into the impact of race, ethnicity, and other identity factors (e.g., socioeconomic status, sexual/gender minority status) on the effects of psychedelic substances.

Language: en

Keywords

Humans; Minority Groups; Ethnicity; *Suicide; *Psychological Distress; *Hallucinogens/adverse effects; *N-Methyl-3,4-methylenedioxyamphetamine/adverse effects; Psilocybin/pharmacology